TY - JOUR
T1 - Analysis of telomere length and subtelomeric methylation of circulating leukocytes in women with Alzheimer's disease
AU - Guan, Jing Zhi
AU - Guan, Wei Ping
AU - Maeda, Toyoki
AU - Makino, Naoki
N1 - Funding Information:
Acknowledgments We are grateful to thank Mr. Brian Quinn for his linguistic advice. This work was supported by grants from the Ministry of Education, Science, and Culture of Japan (#23590885) and the National Natural Science Fund (NSFC) (81170329/H2501).
PY - 2013/4
Y1 - 2013/4
N2 - Backgrounds and aims: Telomere attrition proceeds with the aging process, and is also associated with aging disease conditions, such as Alzheimer's disease (AD). The aging process also affects subtelomeric methylation status. In the present study, the telomere length and the subtelomeric methylation status in female AD patients were analyzed to see how AD affects telomere structure. Methods: Terminal restriction fragment length of 23 AD patients' peripheral leukocytes was analyzed with methylation sensitive- and insensitive-isoschizomer by Southern blot. Results: AD patients were found to have normal mean telomere lengths (controls; 6.4 ± 0.9 kb, AD; 6.1 ± 0.8 kb, p = 0.131), a proportionally decreased number of the longest telomeres (>9.4 kb) (controls; 30.3 ± 7.9 %, AD; 24.4 ± 8.3 %, p = 0.013), increased medium-sized telomeres (controls; 51.7 ± 3.3 %, AD 55.5 ± 6.4 %, p = 0.015) and unchanged numbers of the shortest telomeres (<4.4 kb) (controls; 18.0 ± 7.8, AD; 20.2 ± 8.9 %, p = 0.371) in their peripheral leukocytes. The subtelomeres of telomeres in the shortest range (<4.4 kb) were more methylated in AD subjects than in controls (controls; 0.21 ± 0.23, AD; 0.41 ± 0.26, p = 0.016). Conclusions: These results may indicate that AD contributes to the loss of cells bearing the shortest telomeres, with hypomethylation of subtelomeres occurring in addition to telomere attrition, resulting in an apparent normal mean telomere length in AD patients. The relatively high subtelomeric methylation status of the shortest telomeres in peripheral blood leukocytes may be a characteristic of AD. This report demonstrates that the epigenetic status of the telomeric region is affected by disease conditions.
AB - Backgrounds and aims: Telomere attrition proceeds with the aging process, and is also associated with aging disease conditions, such as Alzheimer's disease (AD). The aging process also affects subtelomeric methylation status. In the present study, the telomere length and the subtelomeric methylation status in female AD patients were analyzed to see how AD affects telomere structure. Methods: Terminal restriction fragment length of 23 AD patients' peripheral leukocytes was analyzed with methylation sensitive- and insensitive-isoschizomer by Southern blot. Results: AD patients were found to have normal mean telomere lengths (controls; 6.4 ± 0.9 kb, AD; 6.1 ± 0.8 kb, p = 0.131), a proportionally decreased number of the longest telomeres (>9.4 kb) (controls; 30.3 ± 7.9 %, AD; 24.4 ± 8.3 %, p = 0.013), increased medium-sized telomeres (controls; 51.7 ± 3.3 %, AD 55.5 ± 6.4 %, p = 0.015) and unchanged numbers of the shortest telomeres (<4.4 kb) (controls; 18.0 ± 7.8, AD; 20.2 ± 8.9 %, p = 0.371) in their peripheral leukocytes. The subtelomeres of telomeres in the shortest range (<4.4 kb) were more methylated in AD subjects than in controls (controls; 0.21 ± 0.23, AD; 0.41 ± 0.26, p = 0.016). Conclusions: These results may indicate that AD contributes to the loss of cells bearing the shortest telomeres, with hypomethylation of subtelomeres occurring in addition to telomere attrition, resulting in an apparent normal mean telomere length in AD patients. The relatively high subtelomeric methylation status of the shortest telomeres in peripheral blood leukocytes may be a characteristic of AD. This report demonstrates that the epigenetic status of the telomeric region is affected by disease conditions.
UR - http://www.scopus.com/inward/record.url?scp=84887086539&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84887086539&partnerID=8YFLogxK
U2 - 10.1007/s40520-013-0006-0
DO - 10.1007/s40520-013-0006-0
M3 - Article
C2 - 23740629
AN - SCOPUS:84887086539
SN - 1594-0667
VL - 25
SP - 17
EP - 23
JO - Aging Clinical and Experimental Research
JF - Aging Clinical and Experimental Research
IS - 1
ER -